1-3 of 3
Christopher Yee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Patient Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Stratified By Exposure to Lenalidomide or Anti-CD38 Therapy and Double-Class Refractory Status: A Retrospective Electronic Health Record Database Study

Joshua Richter, Peter Feng Wang, Alexa Molinari, Boris Gorsh, Natalie Boytsov, Suzanne Landi, Sue Perera, Prani Paka, Teresa Palumbo, Mei Sheng Duh, Christopher Yee, Anamika Khanal, Sonia Gupta, Ajai Chari
Journal: Blood
Blood (2022) 140 (Supplement 1): 4338–4340.
https://doi.org/10.1182/blood-2022-164918
Published: 2022
Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Pegcetacoplan Using Prince Trial Data Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria

Raymond Wong, Jesse Fishman, Koo Wilson, Mohammed Al-Adhami, Michael Yeh, Zalmai Hakimi, Christopher Yee, Lynn Huynh, Mei Sheng Duh
Journal: Blood
Blood (2022) 140 (Supplement 1): 11435–11437.
https://doi.org/10.1182/blood-2022-160197
Published: 2022
Journal Articles

Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison

Rachel Y Bhak, MS, Nikita Mody-Patel, PharmD, MBA, Scott B. Baver, PhD, Colin Kunzweiler, PhD MS, Christopher Yee, ScM, Sanjana Sundaresan, ScM, Natalia Swartz, MPH, Mei Sheng Duh, ScD, MPH, Sangeeta Krishnan, PharmD, MS, Sujata P. Sarda, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-141667
Published: 2020